MEDIFAST INC

MED refers to the publicly traded stock of Medifast, Inc., a U.S.-based health and wellness company. It trades on the New York Stock Exchange under the ticker MED. The company is best known for its OPTAVIA brand, which offers weight-loss and healthy-living products and related support. MED stock gives investors exposure to the direct-selling and wellness sector.

MED, which represents Medifast, Inc., operates in the health and wellness industry, with a specific focus on weight management and nutrition. Through its OPTAVIA brand, the company provides meal replacements, dietary supplements, and coaching services. As a result, MED may be affected by trends in consumer health, dieting, direct selling, and e-commerce.

The current price of MED stock changes throughout the trading day. For the latest price, please refer to the live quote displayed on this page. That quote reflects real-time market activity, including the most recent trade, daily volume, and price range. Historical prices and longer-term trends can be found in the stock's price history section.

MED is listed on the New York Stock Exchange and typically trades during regular market hours. Its liquidity can vary based on market conditions, news, and investor interest. To assess how actively MED is trading, review the latest volume and average daily volume figures available on this page. Higher volume generally indicates more active trading.

Key metrics for MED include revenue growth, gross margin, operating margin, net income, earnings per share, and cash flow. Investors may also examine customer acquisition trends, retention rates, and the company's balance sheet. These figures are reported in Medifast's quarterly and annual filings, which are available through the SEC and the company's investor relations site.

MED faces risks such as intense competition in the weight-loss and wellness market, reliance on direct-selling and independent coaches, regulatory changes, and shifts in consumer preferences. Economic downturns and interest rate changes can also affect demand and profitability. Investors should review the risk factors disclosed in Medifast's SEC filings for a detailed discussion.